Apremilast;Apremilast;Apremilast 10 MG; 20 MG; 30 MG Oral Tablet

DRUG2 trials

Sponsors

Diamant Thaci, Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions

Erythema Nodosum LeprosumModerate to Severe Plaque Psoriasis

Phase 4

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

WithdrawnNCT03146247

Diamant ThaciModerate to Severe Plaque Psoriasis

Start: 2017-10-23End: 2019-03-01Updated: 2019-04-18

A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum

CompletedNCT04822909

Post Graduate Institute of Medical Education and Research, ChandigarhErythema Nodosum Leprosum

Start: 2019-09-15End: 2020-06-30Updated: 2021-03-30